DC Investments Management’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

DC Investments Management’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50,420	Closed	-$646K	–	377
2019 Q1	$646K	Buy	+50,420	New	+$678K	0.41%	75

Other funds holding MITO

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CCA

Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DC Investments Management's MITO Position: Q2 2019 in Review

DC Investments Management sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q2 2019, closing a stake of 50,420 shares — an estimated $646K sold.

DC Investments Management first reported a position in MITO in Q1 2019 and held it in 1 quarter. The position peaked at $646K in Q1 2019. 7 funds tracked by Wall St. Rank hold MITO as of Q2 2019.

DC Investments Management reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q2 2019 after selling out during the quarter.
DC Investments Management sold 50,420 Stealth BioTherapeutics Corp. ADS shares in Q2 2019, an estimated $646K.
DC Investments Management first reported a position in Stealth BioTherapeutics Corp. ADS in Q1 2019 and held it in 1 quarter.
DC Investments Management's Stealth BioTherapeutics Corp. ADS position peaked at $646K in Q1 2019.
7 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q2 2019.

Based on DC Investments Management's 13F filing for Q2 2019, filed 12 Aug 2019.